Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.70 |
| ▸ | NPC1 | O15118 | 4/20 | 0.70 |
| ▸ | RAB9A | P51151 | 4/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 11/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | LOX | P28300 | 1/20 | 0.50 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1689492 | 1.00 | MAPT (0.70) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL1689490 | 1.00 | MAPT (0.70) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL21436723 | 0.85 | MAPT (0.60) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL16645429 | 0.84 | MAPT (0.81) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL2641828 | 0.83 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL30078720 | 0.83 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29350167 | 0.83 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL2641824 | 0.83 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL305974 | 0.82 | MAPT (1.00) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL305975 | 0.82 | MAPT (1.00) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503528-B2 | Thermoplastic moulding composition with improved weathering resistance | RÖHM GMBH (DE) | 2025-12-23 | — | — | US | claimed |
| CN-119805862-A | Colored photosensitive resin composition, color filter, developing device and preparation method | 阜阳欣奕华新材料科技股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| EP-4165118-B1 | THERMOPLASTIC MOULDING COMPOSITION WITH IMPROVED WEATHERING RESISTANCE | ROEHM GMBH (DE) | 2024-11-06 | — | — | EP | claimed |
| US-20230212333-A1 | THERMOPLASTIC MOULDING COMPOSITION WITH IMPROVED WEATHERING RESISTANCE | RÖHM GMBH (DE) | 2023-07-06 | — | — | US | claimed |
| US-20230203313-A1 | PROCESS FOR COLOURING A THERMOPLASTIC POLYMER | RÖHM GMBH (DE) | 2023-06-29 | — | — | US | claimed |
| EP-4165123-A1 | PROCESS FOR COLOURING A THERMOPLASTIC POLYMER | Röhm GmbH (DE) | 2023-04-19 | — | — | EP | claimed |
| EP-4165118-A1 | THERMOPLASTIC MOULDING COMPOSITION WITH IMPROVED WEATHERING RESISTANCE | Röhm GmbH (DE) | 2023-04-19 | — | — | EP | claimed |
| CN-115698156-A | Method for coloring thermoplastic polymers | 罗姆化学有限责任公司 | 2023-02-03 | — | — | CN | claimed |
| JP-2010508092-A | — | — | 2010-03-18 | — | — | JP | claimed |
| EP-2077900-A2 | METHODS AND SYSTEMS FOR IMMOBILIZING CORNEAL PROSTHESES | SHIUEY, Yichieh (US) | 2009-07-15 | — | — | EP | claimed |
| WO-2008103754-A2 | AESTHETIC INTRAOCULAR IMPLANT | TSENG JANET C (US) | 2008-08-28 | — | — | WO | claimed |
| WO-2008055118-A2 | METHODS AND SYSTEMS FOR IMMOBILIZING CORNEAL PROSTHESES | SHIUEY YICHIEH (US) | 2008-05-08 | — | — | WO | claimed |
| US-12629345-B2 | Methods, compositions, and devices for drug / live cell microarrays | PATHAK HOLDINGS LLC (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260097181-A1 | GRADIENT ANNEALING OF POLYMERIC COMPONENTS | Access Vascular, Inc. (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260035579-A1 | RYLENE-BASED UV CURABLE SECURITY INK COMPOSITIONS | SICPA HOLDING SA (CH) | 2026-02-05 | — | — | US | disclosed |
| WO-2025264839-A1 | GRADIENT ANNEALING OF POLYMERIC COMPONENTS | Access Vascular, Inc. (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-0972223-A1 | LIGHT FILTERING CONTACT LENS | PARAGON VISION SCIENCES, INC. (US) | 2000-01-19 | — | — | EP | disclosed |
| US-5846457-A | Light filtering contact lens method | SPORTSIGHT, LLC | 1998-12-08 | — | — | US | disclosed |
| WO-1998044380-A1 | LIGHT FILTERING CONTACT LENS | PARAGON VISION SCIENCES, INC. (US) | 1998-10-08 | — | — | WO | disclosed |
| US-5617154-A | Light filtering contact lens | FLEXLENS (US) | 1997-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629345-B2 | Methods, compositions, and devices for drug / live cell microarrays | SRMS, FKBP4, MYL4 | MAPT 1283/4885ALDH1A1 2168/4885SMN1; SMN2 4455/4885 |
| US-20260097181-A1 | GRADIENT ANNEALING OF POLYMERIC COMPONENTS | AQP3, AQP1, ELOC | MAPT 595/4885ALDH1A1 4582/4885SMN1; SMN2 218/4885 |
| US-20260035579-A1 | RYLENE-BASED UV CURABLE SECURITY INK COMPOSITIONS | RB1, CDK1, MARK1 | MAPT 2133/4885ALDH1A1 1951/4885SMN1; SMN2 3149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.